Detalles de la búsqueda
1.
Updated progression-free survival and final overall survival with maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial.
Int J Gynecol Cancer
; 34(4): 550-558, 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38129136
2.
Evaluation of Scores to Reflect Toxicity Impact on Quality of Life of Patients With Platinum-Resistant Ovarian Cancer: AURELIA Substudy.
J Natl Compr Canc Netw
; 21(5): 473-479.e4, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37156482
3.
Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial.
Lancet Oncol
; 23(11): 1367-1377, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36183733
4.
Real-Time Detection of ESR1 Mutation in Blood by Droplet Digital PCR in the PADA-1 Trial: Feasibility and Cross-Validation with NGS.
Anal Chem
; 94(16): 6297-6303, 2022 04 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-35416669
5.
Efficacy of maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed, advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial.
Gynecol Oncol
; 164(2): 254-264, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34952708
6.
Regorafenib or Tamoxifen for platinum-sensitive recurrent ovarian cancer with rising CA125 and no evidence of clinical or RECIST progression: A GINECO randomized phase II trial (REGOVAR).
Gynecol Oncol
; 164(1): 18-26, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34696892
7.
Paclitaxel with or without pazopanib for ovarian cancer relapsing during bevacizumab maintenance therapy: The GINECO randomized phase II TAPAZ study.
Gynecol Oncol
; 166(3): 389-396, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35902297
8.
Phase II study of the safety and efficacy of the anti-PD-1 antibody balstilimab in patients with recurrent and/or metastatic cervical cancer.
Gynecol Oncol
; 163(2): 274-280, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34452745
9.
Non-pegylated liposomal doxorubicin (NPLD, Myocet®)â¯+â¯carboplatin in patients with platinum sensitive ovarian cancers: A ARCAGY-GINECO phase IB-II trial.
Gynecol Oncol
; 152(1): 68-75, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30446275
10.
Does a homeopathic medicine reduce hot flushes induced by adjuvant endocrine therapy in localized breast cancer patients? A multicenter randomized placebo-controlled phase III trial.
Support Care Cancer
; 27(5): 1879-1889, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30194492
11.
Effective treatment based on monitoring bESR1 mutations - Authors' reply.
Lancet Oncol
; 24(1): e4, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36603926
12.
Bevacizumab plus neoadjuvant chemotherapy in patients with HER2-negative inflammatory breast cancer (BEVERLY-1): a multicentre, single-arm, phase 2 study.
Lancet Oncol
; 17(5): 600-11, 2016 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-27032301
13.
Weekly paclitaxel, capecitabine, and bevacizumab with maintenance capecitabine and bevacizumab as first-line therapy for triple-negative, metastatic, or locally advanced breast cancer: Results from the GINECO A-TaXel phase 2 study.
Cancer
; 122(20): 3119-3126, 2016 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27412268
14.
Impact of secondary cytoreductive surgery on survival in patients with platinum sensitive recurrent ovarian cancer: analysis of the CALYPSO trial.
Gynecol Oncol
; 136(1): 18-24, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25281492
15.
Association between endocrine adjuvant therapy intake timing and disease-free survival in patients with high-risk early breast cancer: results of a sub-study of the UCBG- UNIRAD trial.
EBioMedicine
; 104: 105141, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38718683
16.
Recommandations pour la pratique clinique Nice/Saint-Paul-de-Vence 20222023 : prise en charge du cancer de l'endomètre localisé.
Bull Cancer
; 110(6S): 6S20-6S33, 2023 Jun.
Artículo
en Francés
| MEDLINE | ID: mdl-37573036
17.
An exceptional case of degenerative endometriosis of the uterine torus.
Clin Case Rep
; 11(3): e7130, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36992666
18.
CHEOPS trial: a GINECO group randomized phase II assessing addition of a non-steroidal aromatase inhibitor to oral vinorelbine in pre-treated metastatic breast cancer patients.
Breast Cancer
; 30(2): 315-328, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36602669
19.
Rucaparib for the Treatment of Metastatic Castration-resistant Prostate Cancer Associated with a DNA Damage Repair Gene Alteration: Final Results from the Phase 2 TRITON2 Study.
Eur Urol
; 84(3): 321-330, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37277275
20.
A GINECO randomized phase II trial of two capecitabine and weekly paclitaxel schedules in metastatic breast cancer.
Breast Cancer Res Treat
; 131(1): 127-35, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21947680